Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression of ErbB2 and ErbB3 in MDA-MB-231 human breast cancer cells by Kim, Woo Kyoung et al.
Nutrition Research and Practice (Nutr Res Pract) 2011;5(4):288-293
http://dx.doi.org/10.4162/nrp.2011.5.4.288
Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression
of ErbB2 and ErbB3 in MDA-MB-231 human breast cancer cells
Woo Kyoung Kim
1, Ji Hae Kim
1, Da Hee Jeong
2, Young Hee Chun
2, Sun Hee Kim




1Department of Food Science and Nutrition, Dankook University, Gyeonggi 448-701, Korea 
2Department of Food and Nutrition, Kookmin University, 861-1 Chongneung-dong, Sungbuk-gu, Seoul 136-702, Korea
3Functional Food and Nutrition Division, Rural National Academy of Agricultural Science, Suwon 441-707, Korea
Abstract
In this study, we investigated the effects of the ethanol extract of aerial parts of Raphanus sativus L. (ERL) on breast cancer cell proliferation 
and gene expression associated with cell proliferation and apoptosis in MDA-MB-231 human breast cancer cells. The MDA-MB-231 cells were
cultured in the presence or absence of various concentrations (100, 200, or 300 μg/mL) of ERL. ERL significantly decreased cell proliferation after
48 h of incubation (P < 0.05). The protein and mRNA expression of ErbB2 were decreased significantly in a dose-dependent manner (P<0 . 0 5 ) .
The protein expression of ErbB3 was decreased significantly at an ERL concentration of 300 μg/mL (P < 0.05), and mRNA expression of ErbB3
was decreased significantly in a dose-dependent manner (P< 0.05). The protein expression of Akt was decreased significantly at the ERL concentration 
of 200 μg/mL (P< 0.05), and the protein expression of pAkt was decreased significantly in a dose-dependent manner (P< 0.05). The mRNA expression
of Akt was decreased significantly at the ERL concentration of 200 μg/mL ERL (P< 0.05). The protein and mRNA expression of Bax were increased
significantly at ERL concentrations of 200 μg/mL or higher (P< 0.05). The protein expression of Bcl2 was increased significantly at ERL concentrations 
of 100 μg/mL or higher (P< 0.05), and mRNA expression of Bcl2 was increased significantly at an ERL concentration of 300 μg/mL (P < 0.05).
In conclusion, we suggest that Raphanus sativus, L. inhibits cell proliferation via the ErbB-Akt pathway in MDA-MB-231 cells.
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Introduction2)
The World Health Organization estimates that the approximate 
12.6 million new cancer cases that occurred in 2008 will be 
increased to 21.3 million in 2030 [1]. Cancer is one of the major 
causes of death worldwide, and its burden is growing. Cancer 
rates in Korea have continued to increase, and 178,816 new cases 
were diagnosed in 2008 [2]. Of those, a total of 12,659 new 
breast cancer cases were reported in 2008 [2]. Among women, 
breast cancer is the second most commonly diagnosed type of 
cancer annually, and it continues to be the most common form 
of cancer being treated from year to year [2]. 
The radish (Raphanus sativus L. leaf), which belongs to the 
cruciferae family, is a common edible leafy vegetable consumed 
in Korea [3]. In a previous study, we reported that the ethanol 
extract of the aerial parts of Raphanus sativus L. (ERL) contained 
52.5 mg of polyphenols and total flavonoids per gram of dried 
leaf. This polyphenol and flavonoid content was superior to that 
of plums, Cornus fruits, persimmons, dried persimmons, and 
peeled sweet persimmons [4]. Beevi et al. [5] reported that the 
total phenolic content of ERL was comparable to other traditional 
rich sources, such as green tea and black tea. Studies have 
demonstrated that there is an association between the regular 
consumption of polyphenol-rich foods or beverages, including 
green tea, blueberry juice, and cranberry juice, and the prevention 
of cancer [6-8]. Therefore, plant polyphenols have received 
increasing attention due to their potential chemopreventive roles 
[9]. Polyphenols defend against free radical-induced toxicity by 
scavenging, metal chelating, and acting as antioxidants [10]. 
Several studies have reported on the antioxidant activities of 
radish leaves [5,11]. An in vitro study showed that R. sativus 
sprout extracts inhibited cell proliferation and induced apoptosis 
in cancer cells [12]. 
In breast cancer, the epidermal growth factor receptor (EGFR) 
is an important oncogene [13]. EGFR is composed of family 
members including ErbB1,  ErbB2, ErbB3, and ErbB4. ErbB2 gene 
amplification has been associated with the development of breast 
cancer in animal models [14]. ErbB3 may act as a physiological 
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substrate for the tyrosine kinase activities of ErbB2, as this 
phosphorylation is dependent on the formation of heterodimers 
with ErbB2 protein [15-17]. The amplification of the ErbB2 gene, 
or the overexpression of ErbB2 protein has been found in human 
breast cancer cells and has been associated with the unregulated 
growth of malignant cells [18]. Apoptosis is an important subject 
in cancer research because it induces a series of marked 
morphological changes that include cell contraction, plasma and 
nuclear membrane blebbing, chromatin condensation, organelle 
relocalization and compaction, and the formation of membrane 
enclosed particles containing intracellular material termed 
apoptotic bodies [19]. The Bcl2 family includes both proapoptotic 
proteins, such as Bax, Bad and Bak, and antiapoptotic proteins, 
such as Bcl2, Bcl-x1, Mcl-1, and Bcl-w [19]. Akt has been shown 
to directly phosphorylate Bad, which causes Bad to dissociate 
from Bcl2, losing its pro-apoptotic function and resulting in cell 
survival [20].
A scientific evaluation of the antiproliferative and/or apoptotic 
effects of R.  sativus L. leaves does not exist. Therefore, to 
understand the potential preventive effects of R. sativus L. leaf 
on human breast cancer, we investigated the expressions of 
ErbB2, ErbB3, Bcl2, Bax, and Akt as proliferation and apoptosis 
indices for a breast cancer cell line treated with ERL.
Materials and Methods
Reagent and chemicals
Aerial parts of radish (Raphanus sativus L.) were purchased 
fresh from Dongsu Farm, Yangpyeong-gun, Korea. They were 
washed thoroughly with distilled water and dried in an oven at 
60℃. After grinding, the powder was extracted with 80% ethanol, 
and the extracts were filtered with filter paper (Whatman No. 
2). The extracts were concentrated in a rotary evaporator at 45℃ 
and subsequently lyophilized and stored at -80℃ until use. 
Dulbecco's modified Eagle's medium/Nutrient Mixture Ham's 
F12 (DMEM/F12) and streptomycin and penicillin were obtained 
from Gibco/BRL (Grand island, NY, USA). Antibodies for ErbB2, 
ErbB3, Bcl2, Bax, and pAkt were purchased from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA, USA) and antibody for Akt 
was purchased from Cell Signaling Technology Inc. (Danvers, 
MA, USA). RIA-grade bovine serum albumin (BSA), transferrin, 
and other reagents were purchased from Sigma (St. Louis, MO, 
USA). 
Cell culture 
MDA-MB-231 human breast cancer cells were purchased from 
the American Type Culture Collection (Rockville, MD, USA). 
The cells were maintained in DMEM/F12 containing 100 ml/L 
of fetal bovine serum (FBS) with 100,000 U/L of penicillin and 
100 mg/L of streptomycin. The medium was replaced every 2-3 
days. To examine ERL on breast cancer cell proliferation, the 
MDA-MB-231 cells were plated in 24 well plates at a density 
of 2.5 × 10
4 cells/mL in DMEM/F12 supplemented with 10% 
FBS. After 48 h of incubation, monolayers were serum-starved 
with DMEM/F12 supplemented with 5 μg/mL of transferrin, 5 
ng/mL of selenium, and 1 mg/mL of bovine serum albumin for 
24 h. After serum starvation, the monolayers were treated and 
incubated in serum free medium (SFM) with vehicle (absolute 
ethanol, 0 ug/mL ERL) or 100, 200, or 300 μg/mL of ERL. 
The ERL was dissolved in absolute ethanol and diluted into 
appropriate concentrations for cell culture and treatment.
Viable cell numbers were estimated 0, 24, or 48 h after the 
cells were exposed to ERL using the 3-[4,5-dimethylthiazol- 
2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, as previously 
described [14]. The experiments were performed independently 
three times. 
Western blotting analysis
MDA-MB-231 cells were plated in a 100 mm dish at a density 
of 1 × 10
5 cells/dish with DMEM/F12 supplemented with 10% 
FBS for 48 h. The cells were incubated in serum free medium 
for 24 h, after which they were incubated in the presence of 
ERL at concentrations of 0, 100, 200, or 300 μg/mL for 48 h. 
Then cell lysates were prepared as previously described [15]. 
The total cell lysates were resolved on a sodium dodecylsulfate 
40-200 g/L polyacrylamide gel and then transferred to a 
polyvinylidene fluoride membrane (Millipore, Bedford, MA). 
Next, the blot was blocked for 1 h in 10 g/L of BSA in TBS-T 
(20 mmol/L Tris-Cl, pH 7.5, 150 mmol/L NaCl, 1 g/L Tween 
20) or 50 g/L of milk TBS-T, after which it was incubated for 
1 h with antibodies (ErbB2, ErbB3, Akt, pAkt, Bcl2, Bax). The 
blot was then incubated with antimouse or antirabbit HRP- 
conjugated antibody. Signals were detected by the enhanced 
chemiluminescence method using Super-Signal West Dura 
Extended Duration Substrate (Pierce, Rockford, IL). Finally, the 
relative abundance of each protein band was analyzed by 
scanning the exposed films densitometrically using an Image J 
Launcher (provided by NCBI). 
Reverse transcriptase polymerase chain reaction
The MDA-MB-231 cells were treated with ERL using the same 
method as for western blotting analysis. Total RNA was isolated 
using Tri-reagent (Sigma), and cDNA was synthesized using 2 
μg of total RNA with SuperScript Ⅱ  reverse transcriptase 
(lnvitrogen). For amplification of the cDNA, primers for ErbB2 
(upstream primer, 5'-CAAGAGTGCACGGCAGAGT-3'; downstream 
primer, 5'-GCCTTACAATGTGGGCATG-3'; annealing at 72℃ 
for 30 sec with 45 cycles), ErbB3 (upstream primer, 5'- CAAG 
AGTGCACGGCAGAGT-3'; downstream primer, 5'- GCCTTAC 
AATGTGGGCATG-3'; annealing at 72℃ for 30 sec with 34 
cycles), Akt (upstream primer, 5'-CAACTTCTCTGTGGCGCA 290 Raphanus sativus L. and breast cancer
Fig. 1 ERL inhibits cell proliferation in MDA-MB-231 cells. MDA-MB-231  cells 
w e re  p la te d  a t a  d e n s it y  o f 2 .5 × 1 0
4 cells/ml in a 24 well  plate with DMEM/F12 
supplemented with 10% FBS. Monolayers were then serum-starved with DMEM/F12 
supplemented  with  5  μg/ml  transferrin,  5  ng/ml  selenium,  and  1  mg/ml  bovine 
serum albumin for 24 h. After serum starvation, the monolayers were incubated in 
serum-free medium with 0, 100, 200, or 300 μg/mL ERL for 0, 24, or 48 h. Each 
bar represents the mean ± S.E. of three independent experiments. Different letters 
indicate  significant  differences  among  groups  at  α = 0.05  as  determined  by 
Duncan's  multiple  range  test.
Fig. 2 ERL reduces protein and mRNA expression of ErbB2 in MDA-MB-231 
cells. For ErbB2  protein expression, MDA-MB-231 cells were plated in a 100 mm 
dish at a density of 1×10
5 cells/dish with DMEM/F12 supplemented with 10% FBS 
for 48 h. The cells were then incubated in serum free medium for 24 h, after which
they were incubated in the presence of ERL at concentrations of 0, 100, 200, or 
300  μg/mL  for  48  h.  Equal  amounts  of  cell lysates  (30  μg)  were  then resolved 
by SDS-PAGE, transferred to a membrane, and probed with ErbB 2 (A). For ErbB 2
mRNA  expression,  the  cells  were  cultured  in  serum-free  medium  with  ERL  at 
concentrations  of  0,  100,  200,  or  300  μg/mL  for  48  h.  Total  RNA w as iso lated 
and  RT-PCR  was  performed  (B).  a)  Photographs  of  the  bands,  which  are 
representative  of  three  independent  experiments.  b)  Quantitative  analysis  of  the 
bands.  Each  bar  represents  the  mean ± S.E.  of  three  independent  experiments. 
Different  letters  indicate  significant  differences  among  groups  at  α = 0.05  as 
determined  by  Duncan's  multiple  range  test.
Fig. 3 ERL reduces protein and mRNA expression of ErbB3 in MDA-MB-231 
cells. For ErbB3 protein expression, MDA-MB-231 cells were seeded in a 100 mm 
dish at a density of 1×10
5 cells/dish with DMEM/F12 supplemented with 10% FBS 
for 48 h. The cells were then incubated in serum free medium for 24 h, after which
they were incubated in the presence of ERL at concentrations of 0, 100, 200, or 
300  μg/mL  for  48  h.  Equal  amounts  of  cell lysates  (30  μg)  were  then resolved 
by SDS-PAGE, transferred to a membrane, and probed with ErbB 3 (A). For ErbB 3
mRNA  expression,  the  cells  were  cultured  in  serum-free  medium  with  ERL  at 
concentrations  of  0,  100,  200,  or  300  μg/mL  for  48  h.  Total  RNA w as iso lated 
and  RT-PCR  was  performed  (B).  a)  Photographs  of  the  bands,  which  are 
representative  of  three  independent  experiments.  b)  Quantitative  analysis  of  the 
bands.  Each  bar  represents  the  mean ± SE  of  three  independent  experiments. 
Different  letters  indicate  significant  differences  among  groups  at  α = 0.05  as 
determined  by  Duncan's  multiple  range  test.
GTG-3'; downstream primer, 5'- GACAGGTGGAAGAACAGC 
TCG-3'; annealing at 72℃ for 1 min sec with 30 cycles), Bcl2 
(upstream primer, 5'- TGTGGATGACTGAGTACCTGAAC-3'; 
downstream primer, 5'- AGCTTTGTTTCATGGAACATCACTG 
AC-3'; annealing at 72℃ for 90 sec with 30 cycles), and Bax 
(upstream primer, 5'- ATGGAGGGGTCCGGGGAG-3'; downstream 
primer, 5'- TGGAAGAAGATGGGCTGA-3'; annealing at 72℃ 
for 40 sec with 40 cycles) were used. The expression of human 
β-actin transcripts was examined as an internal control, as 
described previously [16]. The PCR products were separated on 
a 1% agarose gel and stained with ethidium bromide. The bands 
corresponding to each specific PCR product were quantified by 
densitometric scanning of the exposed film using the Bio-profile 
Bio-IL application (Vilber-Lourmat). 
Statistical analysis
Statistical analyses were performed using Statistical Analysis 
System software (SAS Institute, Cary, NC, USA). The data were 
expressed as means with standard errors and analyzed via analysis 
of variance (ANOVA). Statistically significant differences among 
the means of groups were tested at α = 0.05 using Duncan's 
multiple range test. 
Results
ERL inhibits cell proliferation in MDA-MB-231 cells
An MTT assay was performed to clarify the inhibiting effects 
of ERL on cancer cell proliferation. After 48 h of incubation 
with ERL, cell proliferation was decreased significantly in a 
dose-dependent manner (P < 0.05) (Fig. 1).
ERL suppresses protein and mRNA expressions of ErbB2, ErbB3, 
and Akt in MDA-MB-231 cells
The protein expression of ErbB2 was decreased significantly 
in a dose-dependent manner (P< 0.05) (Fig. 2A), and the mRNA 
expression of ErbB2 was decreased significantly at ERL 
concentrations of 100 μg/mL and higher (P < 0.05) (Fig. 2B). 
The protein expression of ErbB3 was decreased significantly at 
an ERL concentration of 300 μg/mL (P < 0.05) (Fig. 3A), and 
the mRNA expression of ErbB3 was decreased significantly in 
a dose-dependent manner (P < 0.05) (Fig. 3B). The protein Woo Kyoung Kim et al. 291
Fig. 4 ERL reduces protein and mRNA expression of Akt MDA-MB-231 cells. 
For Akt and pAkt protein expression, MDA-MB-231 cells were seeded in a 100 mm 
dish at a density of 1×10
5 cells/dish with DMEM/F12 supplemented with 10% FBS 
for 48 h. The cells were then incubated in serum free medium for 24 h, after which
they were incubated in the presence of ERL at concentrations of 0, 100, 200, or 
300 μg/mL for 48 h. Equal amounts of cell lysates (30 μg) were  then resolved 
by SDS-PAGE, transferred to a membrane, and probed with Akt (A) and pAkt (B). 
For Akt mRNA expression, the cells were cultured in serum-free medium with ERL 
at concentrations of 0, 100, 200, or 300 μg/mL for 48 h. Total RNA was isolated 
and  RT-PCR  was  performed  (C).  a)  Photographs  of  the  bands,  which  are 
representative  of  three  independent  experiments.  b)  Quantitative  analysis  of  the 
bands.  Each  bar  represents  the  mean ± SE  of  three  independent  experiments. 
Different  letters  indicate  significant  differences  among  groups  at  α = 0.05  as 
determined  by  Duncan's  multiple  range  test.
Fig. 5 ERL increases protein and mRNA expression of Bax in MDA-MB-231 
cells. For Bax protein expression, MDA-MB-231 cells were seeded in a 100 mm 
dish at a density of 1×10
5 cells/dish with DMEM/F12 supplemented with 10% FBS 
for 48 h. The cells were then incubated in serum free medium for 24 h, after which
they were incubated in the presence of ERL at concentrations of 0, 100, 200, or 
300 μg/mL for 48 h. Equal amounts of cell lysates (30 μg) were  then resolved 
by SDS-PAGE, transferred to a membrane, and probed with Bax (A). For Bax mRNA 
expression, the cells were cultured in serum-free medium with ERL at concentrations 
of 0, 100, 200, or 300 μg/mL for 48 h. Total RNA was isolated and RT-PCR was 
performed  (B).  a)  Photographs  of  the  bands,  which  are  representative  of  three 
independent experiments. b) Quantitative analysis of the bands. Each bar represents 
the  mean ± S.E.  of  three  independent  experiments.  Different  letters  indicate 
significant  differences  among  groups  at  α = 0.05  as  determined  by  Duncan's 
multiple  range  test.
Fig. 6 ERL increases protein and mRNA expression of Bcl2 in MDA-MB-231 
cells. For Bcl2 protein expression, MDA-MB-231 cells were seeded in a 100 mm 
dish at a density of 1×10
5 cells/dish with DMEM/F12 supplemented with 10% FBS 
for 48 h. The cells were then incubated in serum free medium for 24 h, after which
they were incubated in the presence of ERL at concentrations of 0, 100, 200, or 
300  μg/mL  for  48  h.  Equal  amounts  of  cell lysates  (30  μg)  were  then resolved 
by SDS-PAGE, transferred to a m em brane, and probed with Bcl 2 (A). For mRNA 
expression, the cells were cultured in serum-free medium with ERL at concentrations 
of 0, 100, 200, or 300 μg/mL for 48 h. Total RNA was isolated and RT-PCR was 
performed  (B).  a)  Photographs  of  the  bands,  which  are  representative  of  three 
independent experiments. b) Quantitative analysis of the bands. Each bar represents 
the  mean ± S.E.  of  three  independent  experiments.  Different  letters  indicate 
significant  differences  among  groups  at  α = 0.05  as  determined  by  Duncan's 
multiple  range  test.
expression of AKT and its active form pAKT was decreased 
significantly in a dose-dependent manner (P< 0.05) (Fig. 4A and 
4B). The mRNA expression of ErbB3 was decreased significantly 
in a dose-dependent manner (P < 0.05) (Fig. 4C). 
ERL reduces protein and mRNA expression of Bax, and increases 
protein and mRNA expression of Bcl2 in MDA-MB-231 cells
The protein and mRNA expression of Bax was increased 
significantly in a dose-dependent manner (P< 0.05) (Fig. 5A and 
5B). Furthermore, the protein expression of Bcl2 was increased 
significantly at ERL concentrations of 100 μg/mL ERL and 
higher (P < 0.05) (Fig. 6A), and mRNA expression of Bcl2 was 
increased significantly at ERL concentrations of 300 μg/mL and 
higher (P < 0.05) (Fig. 6B).
Discussion
Epidermal growth factor receptors (EGFR) are composed of 
family members including ErbB1,  ErbB2, ErbB3, and ErbB4. The 
binding of EGFR to EGFR family ligands initiates the formation 
of heterodimers, which activate intercellular kinase domains and 
result in the autophosphorylation of tyrosine residues of intracellular 
domains of the receptors. The phosphorylated forms of these 
receptors then serve as docking sites for the cytoplasmic proteins 
involved in transducing signaling cascades for extracellular 
stimulation. ErbB3 may act as a physiological substrate for the 
tyrosine kinase activities of ErbB2, as this phosphorlylation is 
dependent on the formation of heterodimers with ErbB2 protein 
[15-17]. Slamon et al. [21] observed a significant increase in 
the incidence of ErbB2  gene amplification in node-positive breast 
cancer patients. Cooke et al. [22] reported that the overexpression 
of Erb B2 protein in hyperplastic ductal epithelium from node 
negative breast cancer patients had a significant correlation with 
disease recurrence and decreased survival. EGFR has been 
reported to promote cell proliferation and survival in a variety 292 Raphanus sativus L. and breast cancer
of malignancies, including breast, lung, and pancreatic cancers 
[23,24]. These studies suggest that the downregulation of 
overexpression or amplification of EGFR appears to be related 
to the reduced proliferation of cancer cells [22-25]. Our results 
demonstrate that treatment with ERL inhibited the proliferation 
of MDA-MB-231 human breast cancer cells by decreasing the 
expressions of ErbB2 and ErbB3.
The binding of extracellular ligands to EGFR initiates downs-
tream signaling by activating the PI3K/Akt pathway [26]. 
Alterations of Akt were previously observed in late stage and 
high grade tumors, suggesting that Akt plays an important role 
in tumorogenesis [27,28]. Akt activation induces cell survival 
and suppresses apoptotic death [20]. Caspase 9, Bad, and pro- 
apoptotic transcription factors such as FKHR have been reported 
to be phosphorylated by Akt, resulting in the inhibition of their 
anti-apoptotic activities and contributing to cell survival [29-31]. 
To determine the mechanism that mediates the effects of ERL 
in MDA-MB-231 cells, we investigated its involvement with the 
Akt pathway. Akt has been reported to be an important 
downstream component of PI3K-mediated oncogenic signaling 
[29-31]. Chun et al. [32] suggested that Akt is activated in the 
early stage of carcinogenesis after they found that Akt activity 
was higher in an immortalized HBE cell line than in a carcinogen 
exposed HBE cell line or malignant HBE cell line. They 
suggested that increased Akt protein resulting from Akt 
overexpression is a common feature during the early stage of 
carcinogenessis and that inhibition of Akt might be a potential 
target for chemopreventive therapy. In the view of these finding, 
our results indicate that ERL inhibits the proliferation of 
MDA-MD-231 cells by suppressing the EGFR-Akt pathway. 
This expands our understanding of the antitumorogenic effects 
of ERL treatment. The role of apoptosis in tumorogenesis has 
been extensively studied and it appears that inhibition of 
apoptosis leads to premalignant clonal expansion [33]. Bcl2 or 
Bcl-xL overexpression has been shown to suppress apoptosis 
[34,35], whereas the induction of Bax expression has been shown 
to increase apoptosis in transformed cells [36]. Binder et al. [34] 
showed that the upregulation of Bax was coupled with negative 
tumor grades, C-ErbB2, and proliferation activities, especially 
when Bcl2 expression was downregulated concomitantly. The 
results of this study were consistent with their findings. 
Wolter  et al. [37] demonstrated that in cells undergoing 
apoptosis, a change occurs in the intracellular localization of Bax 
that may form channels or pores allowing the release of factors 
such as cytochrome C from the mitochondria to propagate the 
apoptotic pathway. A substantial loss of cytochrome C can lead 
to cell death. The Bcl2 family controls the release of apoptotic 
inducing factors from mitochondria during apoptosis. The over 
expression of Bcl2 has been reported to block mitochondrial 
release of cytochrome C, preventing apoptosis [33]. Tsuruta et 
al. [38] suggested that the expression of Akt suppressed apoptotic 
stimulus-induced Bax translocation. After translocation to the 
mitochondria, Bax induces the release of cytochrome C, and Akt 
inhibits apoptosis by altering mitochondrial membrane potentials, 
thus inhibiting the release of cytochrome C [39-40]. Our study 
confirms that ERL is capable of inducing apoptosis in MDA- 
MB-231 human breast cancer cells. This agrees with previous 
results from Papi et al. [12] such that 4 methylthio-3 butenyl 
-isothiocyante from Rahapnus sativus L. sprouts had cytotoxic/ 
apoptotic activities in human colon carcinoma cell lines.
In conclusion, our results suggest that radish leaf may be a 
clinically useful antitumor agent because it directly inhibits the 
growth of tumor cells and induces apoptosis.
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